|
FY2025
12 months to Dec 31, 2025
|
FY2024
9 months to Dec 31, 2024
|
|
|---|---|---|
| OPERATING EXPENSES | ||
| Research and development costs | ||
| General and administrative | ||
| Depreciation and amortization | ||
| Total Operating Expenses | ||
| OPERATING LOSS | ||
| Interest earned on marketable securities held in Trust Account | ||
| OTHER (EXPENSE) INCOME | ||
| Government grants | ||
| Interest expense | ||
| Nonrelated party | ||
| Related party | ||
| Interest and dividend income | ||
| Foreign exchange gain (loss) | ||
| OTHER (EXPENSE) INCOME | ||
| Net loss before income tax | ||
| Income tax expense | ||
| Net loss | ||
| Loss per common share, basic (in dollars per share) | ||
| Class A Ordinary Shares | ||
| Class B Ordinary Shares | ||
| Total loss per common share, basic (in dollars per share) | ||
| Loss per common share, diluted (in dollars per share) | ||
| Class A Ordinary Shares | ||
| Class B Ordinary Shares | ||
| Total loss per common share, diluted (in dollars per share) | ||
| Weighted-Average Shares of Common Shares Outstanding, Basic (in shares) | ||
| Class A Ordinary Shares | ||
| Class B Ordinary Shares | ||
| Total weighted-Average Shares of Common Shares Outstanding, Basic (in shares) | ||
| Weighted average shares outstanding, diluted (in Shares) | ||
| Class A Ordinary Shares | ||
| Class B Ordinary Shares | ||
| Total weighted average shares outstanding, diluted (in Shares) | ||
| Weighted-Average Shares of Common Shares Outstanding, Diluted (in shares) | ||
| Other comprehensive (loss) income net of tax: | ||
| Foreign currency translation adjustments | ||
| Change in unrealized gains on short term investments | ||
| Comprehensive loss |
Loading...
